Opendata, web and dolomites

ILO SIGNED

Innovative dual cycle tracking system for contraception and conception on a single device

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ILO project word cloud

Explore the words cloud of the ILO project. It provides you a very rough idea of what is the project "ILO" about.

conveys    opportunity    expertise    variables    levels    profits    relying    cumulative    2016    air    facts    cutting    initially    scientifically    accuracy    dual    seamlessly    back    proven    rely    golden    child    39    valued    pregnant    business    sell    wish    count    2023    carbomed    window    self    first    measuring    strive    algorithms    ovulation    subsequently    app    reliably    700    staff    tool    period    commercialization    time    core    periods    handheld    fashioned    fulfils    irregular    length    ilo    23    menstrual    market    usually    body    natural    bespoke    overcome    500    invasive    stage    precise    temperature    device    exhaled    hence    health    conceiving    accurate    predicts    combination    contraceptive    lack    17    subjective    fairly    progression    stress    reaching    criteria    limitations    women    influencing    tracking    units    million    track    180    bleeding    none    chances    amount    fertile    monitoring    contraception    cycle    predicting    co2    approached    innovative    manner    thanks    billion    edge   

Project "ILO" data sheet

The following table provides information about the project.

Coordinator
CARBOMED MEDICAL SOLUTIONS GMBH & CO KG 

Organization address
address: NEUE STIFTINGTALSTRASSE 2/5 OG
city: GRAZ
postcode: 8010
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Project website https://www.iloveovulation.com/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARBOMED MEDICAL SOLUTIONS GMBH & CO KG AT (GRAZ) coordinator 50˙000.00

Map

 Project objective

Women usually track their menstrual cycle for three main reasons: As a natural contraceptive tool, to increase the chances of conceiving or for health-related reasons. However, monitoring every stage of the cycle in an accurate manner has proven challenging, due to the many variables influencing its progression (e.g. irregular periods, stress, etc.). Currently, there are two main approached to cycle tracking: Cycle tracking devices (which represent the old-fashioned approach, fairly reliable but require self-assessment and expertise to get accuracy), and “cutting edge” app-based cycle tracking methods (which are user-friendly, but rely in subjective facts related to the period - e.g. length or amount of bleeding-, traditional measurements -e.g. core body temperature- and algorithms, and lack accuracy. Hence, none of these approaches fulfils the “golden” criteria of being reliable, precise, simple and non-invasive. At Carbomed, we strive to overcome the limitations of both approaches thanks to our innovative ILO system, the seamlessly combination of a handheld device and an app, that reliably predicts the time of ovulation by relying on a scientifically-based method: Measuring the CO2 levels from exhaled air. ILO conveys the best features from both approaches, being accurate, simple and non-invasive while providing a user-friendly experience thanks to our bespoke app. ILO can be used as a dual cycle tracking device predicting the most fertile window, as a natural contraceptive method, but also as a tracking device for those who want to get pregnant. For Carbomed, ILO represents a large business opportunity, aimed initially at the child wish market and subsequently (and most importantly) at the contraception market valued at €17.6 billion back in 2016. In this way, we expect to sell 180,500 ILO units in the first three years of commercialization, reaching cumulative profits of €23.39 million by 2023. To reach this goal, we will increase our staff count by 700%.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ILO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ILO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

Keelcrab (2019)

Keelcrab the Drone for an automated hull cleaning: fast & essential

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More